(WDH) Waterdrop - Ratings and Ratios
Insurance Brokerage, Medical Crowdfunding, Clinical Trials, CRM Services
WDH EPS (Earnings per Share)
WDH Revenue
Description: WDH Waterdrop
Waterdrop Inc. is a Chinese insurance technology company that operates a multifaceted platform, connecting users with insurance products from various providers. The companys business model revolves around providing online insurance brokerage services, enabling users to access a range of insurance products, including short-term and long-term health and life insurance. Additionally, Waterdrop Inc. has diversified its offerings to include a medical crowdfunding platform, facilitating fundraising for medical expenses, and E-Find, a clinical trial patient recruitment platform that streamlines the process of matching patients with clinical trials for pharmaceutical companies.
By leveraging technology, Waterdrop Inc. has established itself as a key player in Chinas insurance industry. The companys customer relationship management system provides technical services to insurance brokerage and agency companies, further expanding its reach within the industry. With its headquarters in Beijing, China, Waterdrop Inc. was founded in 2016 and has since grown to become a significant entity in the insurance technology space.
Analyzing the
Based on the available data, a forecast for Waterdrop Inc. ADR (WDH) can be constructed. Given the current price of $1.35 and the SMA200 of $1.24, the stock is trending upwards. With a P/E ratio of 8.93 and an RoE of 8.06%, the companys financials indicate a stable and profitable business model. Assuming the company continues to grow its insurance brokerage services and expand its technical services, we can expect a potential price target of $1.60 in the next 6-12 months, representing a 18.5% increase from the current price. However, this forecast is contingent upon the companys ability to maintain its growth trajectory and navigate the competitive insurance technology landscape in China.
Additional Sources for WDH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
WDH Stock Overview
Market Cap in USD | 485m |
Sector | Financial Services |
Industry | Insurance - Diversified |
GiC Sub-Industry | Property & Casualty Insurance |
IPO / Inception | 2021-05-07 |
WDH Stock Ratings
Growth Rating | -37.7 |
Fundamental | 26.4 |
Dividend Rating | 1.0 |
Rel. Strength | -4.72 |
Analysts | 4.6 of 5 |
Fair Price Momentum | 1.20 USD |
Fair Price DCF | 16.29 USD |
WDH Dividends
Dividend Yield 12m | 2.49% |
Yield on Cost 5y | 0.35% |
Annual Growth 5y | -42.26% |
Payout Consistency | 100.0% |
Payout Ratio | 3.5% |
WDH Growth Ratios
Growth Correlation 3m | 63.7% |
Growth Correlation 12m | 86.8% |
Growth Correlation 5y | -49.2% |
CAGR 5y | -36.42% |
CAGR/Max DD 5y | -0.40 |
Sharpe Ratio 12m | -0.08 |
Alpha | 17.57 |
Beta | 0.192 |
Volatility | 41.91% |
Current Volume | 144.1k |
Average Volume 20d | 184.6k |
As of July 04, 2025, the stock is trading at USD 1.40 with a total of 144,102 shares traded.
Over the past week, the price has changed by +3.70%, over one month by -4.76%, over three months by +1.27% and over the past year by +23.81%.
Neither. Based on ValueRay´s Fundamental Analyses, Waterdrop is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 26.36 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of WDH is around 1.20 USD . This means that WDH is currently overvalued and has a potential downside of -14.29%.
Waterdrop has received a consensus analysts rating of 4.60. Therefore, it is recommended to buy WDH.
- Strong Buy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, WDH Waterdrop will be worth about 1.3 in July 2026. The stock is currently trading at 1.40. This means that the stock has a potential downside of -6.43%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 1.8 | 31.4% |
Analysts Target Price | 1.8 | 31.4% |
ValueRay Target Price | 1.3 | -6.4% |